Skip to main content

What the FDA labels say about taking them together

Levodopa and metoclopramide

Levodopa's FDA label of July 20, 2026 names metoclopramide in its drug interactions section, and metoclopramide's label names levodopa too. The levodopa label: “Antagonists and Isoniazid Dopamine D2 receptor antagonists and isoniazid may reduce the effectiveness of levodopa. Monitor patients for worsening Parkinson's symptoms.”

Check it at the source: the levodopa FDA label on DailyMed (effective July 20, 2026, Merz Pharmaceuticals, LLC); the metoclopramide FDA label on DailyMed (effective May 18, 2026, ANI Pharmaceuticals, Inc.).

What does the levodopa label say about metoclopramide?

Levodopa label, drug interactions

Antagonists and Isoniazid Dopamine D2 receptor antagonists (e.g., phenothiazines, butyrophenones, risperidone, metoclopramide) and isoniazid may reduce the effectiveness of levodopa. Monitor patients for worsening Parkinson's symptoms.

Source: FDA drug label (Inbrija), Merz Pharmaceuticals, LLC, effective July 20, 2026 (SPL set 077c0f39-a3a2-4b2b-a184-09131889dcfb), via openFDA; the full label on DailyMed

What does the metoclopramide label say about levodopa?

Metoclopramide label, drug interactions

Examples; apomorphine, bromocriptine, cabergoline, levodopa, pramipexole, ropinirole, and rotigotine

Source: FDA drug label (Metoclopramide), NDA017854 (Ani Pharms), as published by ANI Pharmaceuticals, Inc., effective May 18, 2026 (SPL set 797aad80-0597-42f8-99d5-39de180c3b5a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Levodopa generic labelers
39Metoclopramide generic labelers
LevodopaMetoclopramide
Labeled forParkinson's diseaseAcid reflux and ulcers, Nausea and vomiting
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$0.0439 per tablet 10 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?